The company closed its plan on October 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.98 CNY | -1.62% | -3.34% | +2.20% |
Apr. 26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.20% | 1.61B | |
-4.62% | 12.18B | |
+8.48% | 5.96B | |
+27.61% | 5.45B | |
-6.28% | 4.34B | |
-52.72% | 3.18B | |
+12.93% | 2.75B | |
+30.83% | 2.3B | |
-3.80% | 2.28B | |
-4.64% | 1.92B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Sansure Biotech Inc.'s Equity Buyback announced on October 21, 2022, has closed with 9,865,793 shares, representing 1.7% for CNY 200 million.